Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses

38
15
Favorite

Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses

Bloomberg2021-02-17

The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（15）

weijie123
·2021-02-18
Nice
Reply
Like
Report
DannyTan
·2021-02-18
Cool
Reply
Like
Report
Taozi
·2021-02-18
[微笑] [微笑]
Reply
1
Report
Fold Replies
- Taozi:
  ??
  2021-02-18
  Reply
  Report
- weijie123:
  good
  2021-02-18
  Reply
  Report
Big__Boss
·2021-02-18
nice
Reply
Like
Report
reeve
·2021-02-18
Let's see how it goes from here. Accumulation continues.
Reply
Like
Report
Chororo
·2021-02-17
Huat
Reply
1
Report
xralphed
·2021-02-17
Wow
Reply
Like
Report
华尔街挤奶员
·2021-02-17
害.利好2個月，每天都在陰跌.
Reply
2
Report
Jvalour
·2021-02-17
Great
Reply
2
Report
Fold Replies
- Bubu0106:
  ??
  2021-02-17
  Reply
  Report
Baper
·2021-02-17
Yay
Reply
1
Report
Baper
·2021-02-17
Yay
Reply
1
Report
Fold Replies
- Big__Boss:
  nice
  2021-02-18
  Reply
  Report
JosephHo
·2021-02-17
Good
Reply
1
Report
Fold Replies
- JosephHo:
  yay
  2021-02-17
  Reply
  Report
LaoWang
·2021-02-17
Hope Pfizer will gain
Reply
2
Report
Fold Replies
- Kok:
  you bought them?
  2021-02-18
  Reply
  Report
- Big__Boss:
  pfizer gogo
  2021-02-18
  Reply
  Report
Big__Boss
·2021-02-17
nice
Reply
2
Report
ZY95
·2021-02-17
Wo
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1171944463?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-02-17 17:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171944463","market":"us","top_or_hot":-1,"title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","media":"Bloomberg","content":"<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","article_id":"1171944463","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","pubTimestamp":1613553025,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"translate_title":"欧洲与辉瑞生物技术公司达成2亿剂量的合作协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"PFE":0.9},"content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":384959537,"gmtCreate":1613608923829,"gmtModify":1704882638886,"author":{"id":"3575205207637336","authorId":"3575205207637336","name":"weijie123","avatar":"https://static.tigerbbs.com/f79451a0e5ae21cfbd9c59c760eed0a7","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384959537","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":384981773,"gmtCreate":1613606682492,"gmtModify":1704882601922,"author":{"id":"3569973075109763","authorId":"3569973075109763","name":"DannyTan","avatar":"https://static.tigerbbs.com/890baf4ba6385f3e1ad178cfed1843a5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384981773","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":384911194,"gmtCreate":1613605767418,"gmtModify":1704882587763,"author":{"id":"3569931251743015","authorId":"3569931251743015","name":"Taozi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"[微笑]&nbsp;[微笑]&nbsp;","listText":"[微笑]&nbsp;[微笑]&nbsp;","text":"[微笑] [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/384911194","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3600497,"gmtCreate":1613650819923,"gmtModify":1680777383284,"authorId":3569931251743015,"author":{"id":3569931251743015,"authorId":3569931251743015,"name":"Taozi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":384911194,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"},{"id":3595617,"gmtCreate":1613608940874,"gmtModify":1680777304455,"authorId":3575205207637336,"author":{"id":3575205207637336,"authorId":3575205207637336,"name":"weijie123","avatar":"https://static.tigerbbs.com/f79451a0e5ae21cfbd9c59c760eed0a7","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.21%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":384911194,"type":1,"supId":0,"prevId":0,"content":"good","text":"good","html":"good"}],"langContent":"CN"},{"id":384911906,"gmtCreate":1613605699805,"gmtModify":1704882587598,"author":{"id":"3570517865216539","authorId":"3570517865216539","name":"Big__Boss","avatar":"https://static.tigerbbs.com/2c36c2fe68f671064d7d1fd9b7268165","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384911906","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":384994661,"gmtCreate":1613604537253,"gmtModify":1704882566308,"author":{"id":"3574669353038503","authorId":"3574669353038503","name":"reeve","avatar":"https://community-static.tradeup.com/news/f54bbbddcd63aa6ec435193a97c18f3d","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Let's see how it goes from here. Accumulation continues.","listText":"Let's see how it goes from here. Accumulation continues.","text":"Let's see how it goes from here. Accumulation continues.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384994661","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":385786180,"gmtCreate":1613576179140,"gmtModify":1704882348957,"author":{"id":"3548890322785063","authorId":"3548890322785063","name":"Chororo","avatar":"https://static.tigerbbs.com/0cbcbb673621a63bd8bb2f8219eded23","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Huat","listText":"Huat","text":"Huat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385786180","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":385498240,"gmtCreate":1613570585980,"gmtModify":1704882177451,"author":{"id":"3569295655221877","authorId":"3569295655221877","name":"xralphed","avatar":"https://static.tigerbbs.com/5ac77e27d44c5f8e58ba70bc5980c6c4","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385498240","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":385401824,"gmtCreate":1613569440368,"gmtModify":1704882163503,"author":{"id":"3548452324602034","authorId":"3548452324602034","name":"华尔街挤奶员","avatar":"https://static.tigerbbs.com/8c72c8196781549d9c4d8e62dae4768d","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"害.利好2個月，每天都在陰跌.","listText":"害.利好2個月，每天都在陰跌.","text":"害.利好2個月，每天都在陰跌.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385401824","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":385567493,"gmtCreate":1613565434112,"gmtModify":1704882104147,"author":{"id":"3570530631542520","authorId":"3570530631542520","name":"Jvalour","avatar":"https://static.tigerbbs.com/dabcad43bda9229fb25d582c8c1ec36b","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/385567493","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3591765,"gmtCreate":1613570006296,"gmtModify":1680777248752,"authorId":3575191923496169,"author":{"id":3575191923496169,"authorId":3575191923496169,"name":"Bubu0106","avatar":"https://static.tigerbbs.com/d77c5b4980b3cb19d22f467d36ed248b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385567493,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"}],"langContent":"EN"},{"id":385563255,"gmtCreate":1613564873677,"gmtModify":1704882095092,"author":{"id":"3574683709420484","authorId":"3574683709420484","name":"Baper","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Yay","listText":"Yay","text":"Yay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385563255","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":385563825,"gmtCreate":1613564867567,"gmtModify":1704882095254,"author":{"id":"3574683709420484","authorId":"3574683709420484","name":"Baper","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Yay","listText":"Yay","text":"Yay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/385563825","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3595207,"gmtCreate":1613605575637,"gmtModify":1680777299334,"authorId":3570517865216539,"author":{"id":3570517865216539,"authorId":3570517865216539,"name":"Big__Boss","avatar":"https://static.tigerbbs.com/2c36c2fe68f671064d7d1fd9b7268165","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.03","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385563825,"type":1,"supId":0,"prevId":0,"content":"nice","text":"nice","html":"nice"}],"langContent":"EN"},{"id":385513866,"gmtCreate":1613563168655,"gmtModify":1704882067490,"author":{"id":"3575260924648045","authorId":"3575260924648045","name":"JosephHo","avatar":"https://static.tigerbbs.com/b18bd342ec6a173ee43df6269f056c9b","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/385513866","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3590788,"gmtCreate":1613563180186,"gmtModify":1680777234121,"authorId":3575260924648045,"author":{"id":3575260924648045,"authorId":3575260924648045,"name":"JosephHo","avatar":"https://static.tigerbbs.com/b18bd342ec6a173ee43df6269f056c9b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385513866,"type":1,"supId":0,"prevId":0,"content":"<u>yay</u>","text":"<u>yay</u>","html":"<u>yay</u>"}],"langContent":"EN"},{"id":385275406,"gmtCreate":1613559797805,"gmtModify":1704882022200,"author":{"id":"3567562544480318","authorId":"3567562544480318","name":"LaoWang","avatar":"https://static.tigerbbs.com/731b6375b3604a568033aa4981d2d8c9","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Hope Pfizer will gain","listText":"Hope Pfizer will gain","text":"Hope Pfizer will gain","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/385275406","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3595547,"gmtCreate":1613608529191,"gmtModify":1680777306693,"authorId":3560204717545571,"author":{"id":3560204717545571,"authorId":3560204717545571,"name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.18","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2007},"crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.21","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":385275406,"type":1,"supId":3595209,"prevId":0,"content":"you bought them?","text":"you bought them?","html":"you bought them?"},{"id":3595209,"gmtCreate":1613605589673,"gmtModify":1680777299415,"authorId":3570517865216539,"author":{"id":3570517865216539,"authorId":3570517865216539,"name":"Big__Boss","avatar":"https://static.tigerbbs.com/2c36c2fe68f671064d7d1fd9b7268165","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.03","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385275406,"type":1,"supId":0,"prevId":0,"content":"pfizer gogo","text":"pfizer gogo","html":"pfizer gogo"}],"langContent":"EN"},{"id":385254477,"gmtCreate":1613557925999,"gmtModify":1704881999123,"author":{"id":"3570517865216539","authorId":"3570517865216539","name":"Big__Boss","avatar":"https://static.tigerbbs.com/2c36c2fe68f671064d7d1fd9b7268165","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385254477","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":385258847,"gmtCreate":1613557541289,"gmtModify":1704881992933,"author":{"id":"3575879813755575","authorId":"3575879813755575","name":"ZY95","avatar":"https://static.tigerbbs.com/3b057a08c7bda4c5308522a6721fe295","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Wo","listText":"Wo","text":"Wo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385258847","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":38,"commentSize":15,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}